India Cardiac Disease Market Outlook to 2036

India Cardiac Disease Market Outlook to 2036 - Cardiac Marker Tests

Summary

The analyst’s “India Cardiac Disease Market Outlook to 2036” is a comprehensive databook report, covering key market data on the India Cardiac Disease market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cardiac Marker Tests

The India Cardiac Disease Market report provides key information and data on:

Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2024 to 2036.
2025 company share data for Cardiac Disease Market.
Global corporate-level profiles of key companies operating within the India Cardiac Disease Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

India Cardiac Disease is segmented as follows:

Cardiac Marker Tests

Reasons to Buy

The India Cardiac Disease Market report helps you to develop:

Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

1 Introduction

1.1 What Is This Report About?
1.2 Cardiac Disease Market Segmentation
1.3 Definitions of Markets Covered in the Report

2 Cardiac Disease Market, India

2.1 Cardiac Disease Market, India, Revenue ($m), 2024-2036
2.1.1 Cardiac Marker Tests Market, India, Revenue ($m), by Segment, 2024-2036
2.2 Cardiac Disease Market, India, Volume (Units), 2024-2036
2.2.1 Cardiac Marker Tests Market, India, Volume (Units), by Segment, 2024-2036
2.3 Cardiac Disease Market, India, Average Price ($), 2024-2036
2.4 Cardiac Disease Market, India, Company Share by Revenue ($m), 2025

3 Cardiac Disease Market Pipeline Products

3.1 Cardiac Disease Market Pipeline Products
3.2 Cardiac Disease - Pipeline Products by Stage of Development
3.3 Cardiac Disease - Pipeline Products by Segment
3.4 Cardiac Disease - Pipeline Products by Territory
3.5 Cardiac Disease - Pipeline Products by Regulatory Path
3.6 Cardiac Disease - Pipeline Products by Estimated Approval Date

4 Overview of Key Companies in India, Cardiac Disease Market

4.1 F. Hoffmann-La Roche Ltd
4.1.1 Company Overview
4.2 Abbott Laboratories
4.2.1 Company Overview
4.3 Siemens Healthineers AG
4.3.1 Company Overview
4.4 Quidel Corp
4.4.1 Company Overview
4.5 Beckman Coulter Inc
4.5.1 Company Overview
4.6 bioMerieux SA
4.6.1 Company Overview

5 Recent Developments

5.1 Product News
5.1.1 Feb 12, 2026: HRS Releases Scientific Statement on Pulsed Field Ablation for Cardiac Arrhythmias
5.1.2 Sep 17, 2025: AI Outperforms Doctors In Predicting Surgical Complications

6 Appendix

6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Benchmarking
6.2 the Analyst Consulting
6.3 Contact Us
6.4 Disclaimer

List of Tables

Table 1: Cardiac Disease Market, India, Revenue ($m), USD Constant, 2024-2036
Table 2: Cardiac Marker Tests Market, India, Revenue ($m), USD Constant, 2024-2036
Table 3: Cardiac Disease Market, India, Volume (Units), 2024-2036
Table 4: Cardiac Marker Tests Market, India, Volume (Units), 2024-2036
Table 5: Cardiac Disease Market, India, Average Price ($), 2024-2036
Table 6: Cardiac Disease Market, India, Company Share by Revenue ($m), USD Constant, 2025
Table 7: Cardiac Disease Market Pipeline Products
Table 8: Cardiac Disease - Pipeline Products by Stage of Development
Table 9: Cardiac Disease Companies - Pipeline Products by Stage of Development
Table 10: Cardiac Disease - Pipeline Products by Segment
Table 11: Cardiac Disease - Pipeline Products by Territory
Table 12: Cardiac Disease - Pipeline Products by Regulatory Path
Table 13: Cardiac Disease - Pipeline Products by Estimated Approval Date
Table 14: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country

List of Figures

Figure 1: Cardiac Disease Market, India, Revenue ($m), USD Constant, 2024-2036
Figure 2: Cardiac Marker Tests Market, India, Revenue ($m), USD Constant, 2024-2036
Figure 3: Cardiac Disease Market, India, Volume (Units), 2024-2036
Figure 4: Cardiac Marker Tests Market, India, Volume (Units), 2024-2036
Figure 5: Cardiac Disease Market, India, Company Share (%), 2025
Figure 6: Cardiac Disease - Pipeline Products by Stage of Development
Figure 7: Cardiac Disease - Pipeline Products by Segment
Figure 8: Cardiac Disease - Pipeline Products by Territory
Figure 9: Cardiac Disease - Pipeline Products by Regulatory Path
Figure 10: Cardiac Disease - Pipeline Products by Estimated Approval Date

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

F. Hoffmann-La Roche Ltd
Abbott Laboratories
Siemens Healthineers AG
Quidel Corp
Beckman Coulter Inc
bioMerieux SA

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4627EUR$4,995USD£3,911GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€9254EUR$9,990USD£7,822GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€13881EUR$14,985USD£11,733GBP